Long-Term Follow-Up of Patients with 46,XY Partial Gonadal Dysgenesis Reared as Males

Background/Aims. Studies on 46,XY partial gonadal dysgenesis (PGD) have focused on molecular, gonadal, genital, and hormone features; little is known about follow-up. Our aim was to analyze long-term outcomes of PGD. Methods. Retrospective longitudinal study conducted at a reference service in Brazil. Ten patients were first evaluated in the 1990s and followed up until the 2010s; follow-up ranged from 13.5 to 19.7 years. All were reared as males and had at least one scrotal testis; two bore NR5A1 mutations. Main outcomes were: associated conditions, pubertal development, and growth. Results. All patients had normal motor development but three presented cognitive impairment; five had various associated conditions. At the end of the prepubertal period, FSH was high or high-normal in 3/6 patients; LH was normal in all. At the last evaluation, FSH was high or high-normal in 8/10; LH was high or high-normal in 5/10; testosterone was decreased in one. Final height in nine cases ranged from −1.57 to 0.80 SDS. All had spontaneous puberty; only one needed androgen therapy. Conclusions. There is good prognosis for growth and spontaneous pubertal development but not for fertility. Though additional studies are required, screening for learning disabilities is advisable.

[1]  G. Guerra‐Júnior,et al.  The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency , 2014, BMC Medical Genetics.

[2]  T. Ogata,et al.  A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and/or depression , 2013, Clinical endocrinology.

[3]  H. Biebermann,et al.  Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations , 2012, European journal of endocrinology.

[4]  G. Guerra‐Júnior,et al.  Complete gonadal dysgenesis in clinical practice: the 46,XY karyotype accounts for more than one third of cases. , 2011, Fertility and sterility.

[5]  John C. Achermann,et al.  Steroidogenic factor-1 (SF-1, NR5A1) and human disease , 2011, Molecular and Cellular Endocrinology.

[6]  N. Sebire,et al.  Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. , 2010, American journal of human genetics.

[7]  B. Köhler,et al.  Update--steroidogenic factor 1 (SF-1, NR5A1). , 2010, Minerva endocrinologica.

[8]  G. Guerra‐Júnior,et al.  46,XY and 45,X/46,XY testicular dysgenesis: similar gonadal and genital phenotype, different prognosis. , 2010, Arquivos brasileiros de endocrinologia e metabologia.

[9]  Organización Mundial de la Salud WHO laboratory manual for the examination and processing of human semen , 2010 .

[10]  J. Achermann,et al.  Steroidogenic Factor-1 (SF-1, Ad4BP, NR5A1) and Disorders of Testis Development , 2008, Sexual Development.

[11]  S. Ahmed,et al.  Consensus Statement on Management of Intersex Disorders , 2006, Pediatrics.

[12]  L. Looijenga,et al.  Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. , 2006, Endocrine reviews.

[13]  A. Maciel-Guerra,et al.  Mutations in SRY and WT1 genes required for gonadal development are not responsible for XY partial gonadal dysgenesis. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  J. Simpson,et al.  Abnormalities of human sex chromosomes , 1974, Humangenetik.

[15]  T. Yokoi,et al.  Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. , 2004, Drug metabolism and pharmacokinetics.

[16]  G. Júnior,et al.  A importância da análise histológica morfométrica gonadal na identificação da gônada disgenética , 2003 .

[17]  H. Chemes,et al.  Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour development , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  K. Okamura,et al.  Complete XY gonadal dysgenesis and aspects of the SRY genotype and gonadal tumor formation , 2002, Journal of Human Genetics.

[19]  K. Kula,et al.  Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. , 2001, Journal of andrology.

[20]  M. Palandi de Mello,et al.  Morphometry and histology of gonads from 13 children with dysgenetic male pseudohermaphroditism. , 2001, Archives of pathology & laboratory medicine.

[21]  T. MacDonald,et al.  Prevalence and aetiology of hypothyroidism in the young , 2000, Archives of disease in childhood.

[22]  E. Perlman,et al.  Analysis of the SRY gene in gonadal tissue of subjects with 46,XY gonadal dysgenesis. , 1997, Journal of Clinical Endocrinology and Metabolism.

[23]  P. Goodfellow,et al.  Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. , 1992, American journal of human genetics.

[24]  I. Verma,et al.  Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism—A critical analysis , 1992, Indian journal of pediatrics.

[25]  E. Hook Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. , 1977, American journal of human genetics.

[26]  J M Tanner,et al.  Standards for Children's Height at Ages 2-9 Years Allowing for Height of Parents , 1970, Archives of disease in childhood.

[27]  J. German Abnormalities of human sex chromosomes. V. A unifying concept in relation to the gonadal dysgeneses , 1970 .